Brainstorm Cell Therapeutics reported $1.2M in Debt for its fiscal quarter ending in March of 2025.





Debt Change Date
Alterity Therapeutics Limited AUD 210.39K 120.67K Jun/2023
Biogen USD 7.69B 398.3M Sep/2026
Brainstorm Cell Therapeutics USD 1.2M 1.2M Mar/2025
Cipla INR 6.99B 857M Sep/2026
Clal Biotechnology ILS 35.76M 28.27M Dec/2023
Compugen USD 3.02M 91K Jun/2026
CSL USD 11.96B 219M Dec/2024
Cytokinetics USD 1.27B 18.17M Jun/2026
Gilead Sciences USD 26.25B 4.07B Jun/2026
Grifols EUR 9.23B 626.05M Dec/2024
Halozyme Therapeutics USD 2.15B 2.02M Jun/2026
Mesoblast USD 135.14M 6.99M Dec/2025